| # | Drug | Count |
|---|---|---|
| 0 | RANIBIZUMAB | 71 |
| 1 | BEVACIZUMAB | 47 |
| 2 | AFLIBERCEPT | 40 |
| 3 | SILDENAFIL CITRATE | 24 |
| 4 | ASPIRIN | 23 |
| 5 | QUININE | 22 |
| 6 | ASPIRIN 325 MG | 21 |
| 7 | ASPIRIN 81 MG | 21 |
| 8 | BROLUCIZUMAB | 20 |
| 9 | INSULIN GLARGINE | 20 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADALIMUMAB-AQVH | 1 | 0.0101 |
| 1 | AFLIBERCEPT-AYYH | 1 | 0.0099 |
| 2 | BROLUCIZUMAB | 20 | 0.0055 |
| 3 | VERTEPORFIN FOR INJECTION | 8 | 0.0054 |
| 4 | BEVACIZUMAB-MALY | 1 | 0.0050 |
| 5 | PEGCETACOPLAN | 6 | 0.0032 |
| 6 | TROPICAMIDE | 5 | 0.0031 |
| 7 | CARTEOLOL HYDROCHLORIDE | 1 | 0.0030 |
| 8 | RANIBIZUMAB | 71 | 0.0027 |
| 9 | QUININE | 22 | 0.0026 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 144 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 48 |
| 2 | Corticosteroid [EPC] | 46 |
| 3 | Insulin Analog [EPC] | 33 |
| 4 | Benzodiazepine [EPC] | 23 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 23 |
| 6 | Prostaglandin Analog [EPC] | 16 |
| 7 | Proton Pump Inhibitor [EPC] | 14 |
| 8 | Vitamin C [EPC] | 14 |
| 9 | Platinum-based Drug [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 1 | Photoenhancer [EPC] | 8 | 0.0021 |
| 2 | Diagnostic Dye [EPC] | 1 | 0.0015 |
| 3 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 4 | Antiseptic [EPC] | 5 | 0.0011 |
| 5 | Interleukin-17 Receptor A Antagonist [EPC] | 2 | 0.0010 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 144 | 0.0008 |
| 7 | alpha-1 Adrenergic Agonist [EPC] | 3 | 0.0007 |
| 8 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 9 | Monoamine Oxidase Inhibitor [EPC] | 1 | 0.0003 |